US Stock MarketDetailed Quotes

GWW W.W. Grainger

Watchlist

990.200
-1.390-0.14%

Close Mar 25 16:00 ET

990.200
0.0000.00%

Post 20:01 ET

47.70BMarket Cap25.58P/E (TTM)

W.W. Grainger Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

W.W. Grainger Q4 2024 Earnings Date

Currency：USDJan 31, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	4.24B	4.23B	-6.32M
Miss Est.	+6.06%	+5.90%	-0.15%
EPS	9.75	9.71	-0.04
Miss Est.	+23.62%	+23.07%	-0.45%

Analyst Rating

Hold

Mar 10, 2025

W.W. Grainger Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 16 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Jul 31, 2025	2025/Q2	-- / 4.510B	--
May 1, 2025	2025/Q1	-- / 4.313B	--
Jan 31, 2025	2024/Q4	4.233B / 4.239B	--
Oct 31, 2024	2024/Q3	4.388B / 4.399B	--
Aug 1, 2024	2024/Q2	4.312B / 4.351B	--

DatePeriodRevenue/EstimateEarnings Call

Jul 31, 20252025/Q2-- / 4.510B--

May 1, 20252025/Q1-- / 4.313B--

Jan 31, 20252024/Q44.233B / 4.239B--

Oct 31, 20242024/Q34.388B / 4.399B--

Aug 1, 20242024/Q24.312B / 4.351B--

Unlock Free Earnings Estimates

Open Account

W.W. Grainger Earnings Reports

W.W. Grainger | 10-K: FY2024 Annual Report

Feb 20 16:47 ET

W.W. Grainger | 8-K: GRAINGER REPORTS RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2024

Jan 31 08:36 ET

W.W. Grainger | 10-Q: Q3 2024 Earnings Report

Oct 31, 2024 16:36 ET

W.W. Grainger | 8-K: GRAINGER REPORTS RESULTS FOR THE THIRD QUARTER 2024

Oct 31, 2024 08:30 ET

Market Insights

Symbol Mini Chart % Chg

Halozyme Therapeutics

Unlock the Full List

Analysis

Analyst Rating

Updated: Mar 10, 2025

Hold

Buy
22.22%
Hold
66.67%
Sell
11.11%

Price Target

No Data

Investment Theme

Dividend Aristocrats

Intraday-1.38%